The Programme consists of a follow-up study of bladder cancer patients recruited via 16 urology centres in the West Midlands and a bladder cancer Biobank.
The Bladder Cancer Prognosis Programme (BCPP) recruited over 1300 bladder cancer patients between 2005 and 2011. The biospecimen collection, comprising fresh-frozen bladder cancer tissues as well as blood and urine, has grown to be one of the world’s largest and most detailed providing a unique resource for a wide array of bladder cancer studies. Each biological sample is linked to over one thousand variables containing clinical, epidemiological and pathological data. All samples have also been linked to follow up data on recurrence and progression.